Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer.
Dongfang ChenJianlin XuYizhuo ZhaoBaohui HanRunbo ZhongPublished in: Cancer biology & therapy (2024)
Pretreatment PCT is an independent factor associated with PFS in extensive-stage SCLC patients treated with first-line chemotherapy, but pretreatment NLR reflects no significant prognostic value in our study.